An Open-Label Phase 1/2 Study of JCARH125, BCMA targeted Chimeric Antigen Receptor (CAR) T Cells, in Subjects with Relapsed or Refractory Multiple Myeloma

Type of Cancer
Multiple Myeloma

Site
Hackensack

Sponsor
JUNO

Protocol Number
H125001

To Learn More Call
(201)-510-0950